Skip to content

Clinical trials

Leukemia, Myelomonocytic, Chronic trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Country / region: New Zealand Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20191
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aptose Biosciences Inc.1
Children's Oncology Group1
National Cancer Institute (NCI)1
Otsuka Australia Pharmaceutical Pty Ltd1
The Canadian Blood and Marrow Transplant Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic5
Leukemia, Myeloid, Acute3
Myelodysplastic Syndromes3
Myeloproliferative Disorders3
Anemia, Refractory2
Anemia, Refractory, with Excess of Blasts2
Leukemia2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Primary Myelofibrosis2
Recurrence2

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.